Glutamine Claim Class Action Against GNC Gets Wide Berth For Relevant Studies
This article was originally published in The Rose Sheet
An Illinois federal judge denies GNC motion to dismiss based partly on argument that studies of products with different formulations or delivery formats than the challenged Pro Performance supplements are inappropriate as evidence for the complaint alleging consumer fraud.
You may also be interested in...
Two years after Bayer prevailed against FTC's demand for RCTs to substantiate claims for its Phillips Colon Health probiotic, a judge dismisses a class action complaint targeting the product, saying the plaintiffs did not support their argument and their expert expected supplements to be evaluated as drugs.
NAD advises Fit Products to modify FitTea claims because its formulation is not the same as studies submitted and reminds the firm that testimonials must not contain false claims about products.
UK pharma announced that in 2021 it will close its manufacturing facility in Carlisle, PA, where around 260 people are employed making the Emergen-C line. It will move the manufacturing to its Guayama, PR, facility.